Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups

References

• KearneyPMWheltonMReynoldsKMuntnerPWheltonPKHeJGlobal burden of hypertension: analysis of worldwide dataLancet200536521722315652604
   PubMed Web of Science ®Google Scholar
• ChowCKTeoKKRangarajanSPrevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-,middle-, and low-income countriesJAMA201331095996824002282
   PubMed Web of Science ®Google Scholar
• GradmanAHManaging high-risk patients with hypertension: focus on the renin-angiotensin systemJ Clin Hypertens (Greenwich)2004650150815365277
   PubMedGoogle Scholar
• ManciaGFagardRNarkiewiczK2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens2013311281135723817082
   PubMed Web of Science ®Google Scholar
• BramlagePPittrowDWittchenHUHypertension in overweight and obese primary care patients is highly prevalent and poorly controlledAm J Hypertens20041790491015485752
   PubMed Web of Science ®Google Scholar
• EguchiKPickeringTGKarioKWhy is blood pressure so hard to control in patients with type 2 diabetes?J Cardiometab Syndr2007211411817684464
   PubMedGoogle Scholar
• StokesGSManagement of hypertension in the elderly patientClin Interv Aging2009437938919851513
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRSeventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension2003421206125214656957
   PubMed Web of Science ®Google Scholar
• DuprezDTreatment of isolated systolic hypertension in the elderlyExpert Rev Cardiovasc Ther2012101367137323244357
   PubMedGoogle Scholar
• KidambiSKotchenTATreatment of hypertension in obese patientsAm J Cardiovasc Drugs20131316317523579967
   PubMed Web of Science ®Google Scholar
• MallatSGItaniHSTaniosBYCurrent perspectives on combination therapy in the management of hypertensionIntegr Blood Press Control20136697823837009
   PubMedGoogle Scholar
• ChiangCEWangTDLiYH2010 guidelines of the Taiwan Society of Cardiology for the management of hypertensionJ Formos Med Assoc201010974077320970072
   PubMed Web of Science ®Google Scholar
• ChungNBaekSChenMFExpert recommendations on the challenges of hypertension in AsiaInt J Clin Pract2008621306131218643931
   PubMed Web of Science ®Google Scholar
• FujitaTWuZParkJ-BChenM-FBriefings on JHS, CHS, KHS and THS guidelines and their difference from JNC VII and ESC/ESHInt J Clin Pract20066036
   Web of Science ®Google Scholar
• SisonJAssaad-KhalilSHNajemRReal-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE studyCurr Med Res Opin2014301937194525007309
   PubMed Web of Science ®Google Scholar
• PistroschFNataliAHanefeldMIs hyperglycemia a cardiovascular risk factor?Diabetes Care201134Suppl 2S128S13121525443
   PubMedGoogle Scholar
• StearneMRPalmerSLHammersleyMSTight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study GroupBMJ19983177037139732337
   PubMedGoogle Scholar
• SingerGMSetaroJFSecondary hypertension: obesity and the metabolic syndromeJ Clin Hypertens (Greenwich)20081056757418607142
   PubMed Web of Science ®Google Scholar
• LandsbergLAronneLJBeilinLJObesity-related hypertension: pathogenesis, cardiovascular risk, and treatment – a position paper of the The Obesity Society and The American Society of HypertensionObesity (Silver Spring)20132182423401272
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA20032892560257212748199
   PubMed Web of Science ®Google Scholar
• WeberMASchiffrinELWhiteWBClinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of HypertensionJ Clin Hypertens (Greenwich)201416142624341872
   PubMed Web of Science ®Google Scholar
• IzzoJLJrLevyDBlackHRClinical Advisory Statement. Importance of systolic blood pressure in older AmericansHypertension2000351021102410818056
   PubMedGoogle Scholar
• CalhounDALacourciereYCrikelairNJiaYGlazerRDEffects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertensionCurr Med Res Opin20132990191023721363
   PubMed Web of Science ®Google Scholar
• SmithTRPhilippTVaisseBAmlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studiesJ Clin Hypertens (Greenwich)2007935536417485971
   PubMedGoogle Scholar
• FlackJMCalhounDASatlinLBarbierMHilkertRBrunelPEfficacy and safety of initial combination therapy with amlodipine/ valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND studyJ Hum Hypertens20092347948919190658
   PubMed Web of Science ®Google Scholar
• AllemannYFraileBLambertMBarbierMFerberPIzzoJLJrEfficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) studyJ Clin Hypertens (Greenwich)20081018519418326958
   PubMed Web of Science ®Google Scholar
• DestroMLuckowASamsonMKandraABrunelPEfficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS StudyJ Am Soc Hypertens2008229430220409909
   PubMed Web of Science ®Google Scholar
• CalhounDACrikelairNAYe nJGlazerRDAmlodipine/valsartan/ hydrochlorothiazide triple combination therapy in moderate/severe hypertension: secondary analyses evaluating efficacy and safetyAdv Ther2009261012102320024680
   PubMed Web of Science ®Google Scholar
• PoldermansDGlazesRKargiannisSTolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertensionClin Ther20072927928917472820
   PubMed Web of Science ®Google Scholar
• EckertSFreytagSBMullerAKlebsSHMeta-analysis of three observational studies of amlodipine/valsartan in hypertensive patients with additional risk factorsBlood Press201322Suppl 1112123713686
   PubMed Web of Science ®Google Scholar
• KizilirmakPBerktasMYalcinMRBoyaciBEfficacy and safety of valsartan and amlodipine single-pill combination in hypertensive patients (PEAK study)Turk Kardiyol Dern Ars20134140641723917006
   PubMedGoogle Scholar
• HuDLiuLLiWEfficacy and safety of valsartan/amlodipine single-pill Combination in 11,422 Chinese patients with hypertension: an observational studyAdv Ther20143176277524985411
   PubMed Web of Science ®Google Scholar
• DusingROptimizing blood pressure control through the use of fixed combinationsVasc Health Risk Manag2010632132520531950
   PubMedGoogle Scholar